Yu Shan

Founder en SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. .

Fortuna: 54 M $ al 31/03/2024

64 años

99 relaciones

Consumer Services

Health Technology

Process Industries

Perfil

Yu Shan fundó Shenzhen Hepalink Pharmaceutical Group Co. Ltd. En la actualidad, es Director General y Director Ejecutivo de Shenzhen Hepalink Pharmaceutical Group Co., Ltd. y Socio Ejecutivo de Urumqi Shuidishichuan Equity Investment Partnership LP. También forma parte del consejo de administración de Chengdu Hepatunn Pharmaceutical Co. Ltd. y Shenzhen Duopule Industrial Development Co. Se licenció en la Universidad de Pekín.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. CLASS A 3.72%	30/06/2023	46 425 600 ( 3.72% )	54 M $	31/03/2024

Cargos activos de Yu Shan

Empresas	Cargo	Inicio
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.	Founder	21/04/1998
Urumqi Shuidishichuan Equity Investment Partnership LP	Corporate Officer/Principal	-
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million.	Director/Board Member	-
Shenzhen Duopule Industrial Development Co., Ltd. Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million.	Director/Board Member	13/01/2014

Todos los cargos activos de Yu Shan

Formación de Yu Shan.

Peking University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yu Shan.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.	Health Technology

Empresas privadas	3
Urumqi Shuidishichuan Equity Investment Partnership LP
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million.	Process Industries
Shenzhen Duopule Industrial Development Co., Ltd. Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million.	Distribution Services

Ver las conexiones de la empresa